Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs

Go back to Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
Mitsubishi Chemical Holdings Corp Unsponsored ADR (AMEX: MTLHY) Delayed: 36.64 --0 (-0%)
Previous Close $36.64    52 Week High $34.07 
Open $36.64    52 Week Low $21.84 
Day High $36.64    P/E N/A 
Day Low $36.64    EPS $0.00 
Volume 9,700       

Regeneron (NASDAQ: REGN) Delayed: 746.54 --0 (-0%)
Previous Close $746.54    52 Week High $592.36 
Open $746.54    52 Week Low $325.35 
Day High $746.54    P/E 195.94 
Day Low $746.54    EPS $3.81 
Volume 151       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 41.10 --0 (-0%)
Previous Close $41.10    52 Week High $66.55 
Open $41.10    52 Week Low $37.82 
Day High $41.10    P/E N/A 
Day Low $41.10    EPS $0.00 
Volume 25,939